Physician profile
Tamara Copeland
NPI 1457709065
$1,817.35
in general payments reported to CMS, 2019-2025
20 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2022: $90.61 · 2023: $479 · 2024: $509 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,368.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $633.95 | 2022-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $162.50 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $124.96 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbott Laboratories | $122.93 | 2019 | |
| Edwards Lifesciences Corporation | $119.75 | 2019 | |
| Exact Sciences Corporation | $108.69 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $99.61 | 2022-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $77.46 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $67.29 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $61.84 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $52.48 | 2019 | |
| Astellas Pharma US INC | $44.60 | 2024-2025 | Veozah |
| Ethicon INC. | $23.87 | 2024 | Monarch Platform |
| Axsome Therapeutics, INC. | $23.08 | 2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $18.89 | 2025 | Rexulti |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $15.94 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.43 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.30 | 2019 | |
| Axonics, INC. | $14.88 | 2023 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $13.90 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Copeland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.